Search

Your search keyword '"Harada, Masaoki"' showing total 236 results

Search Constraints

Start Over You searched for: Author "Harada, Masaoki" Remove constraint Author: "Harada, Masaoki"
236 results on '"Harada, Masaoki"'

Search Results

1. Identification of Early Biochemical Recurrence Predictors in High-Risk Prostate Cancer Patients Treated with Carbon-Ion Radiotherapy and Androgen Deprivation Therapy

3. External validation of the Candiolo nomogram for high-risk prostate cancer patients treated with carbon ion radiotherapy plus androgen deprivation therapy: a retrospective cohort study

21. Patients with ultrasonic coarse-nodular cirrhosis who are anti-hepatitis C virus-positive are at high risk for hepatocellular carcinoma

23. Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients

24. The male preponderance in incidence of hepatocellular carcinoma in cirrhotic patients may depend on the higher DNA synthetic activity of cirrhotic tissue in men

25. DNA synthesis activaties of hepatocytes from noncancerous cirrhotic tissue and of hepatocellular cirrhotic tissue and of hepatocellular carcinoma (HCC) cells from cancerous tissue can predict the survival of hepatectomized patients with HCC

26. 根治的前立腺全摘除術症例における再発予測についての臨床的検討

28. Biochemical failure after carbon ion radiotherapy for prostate cancer

29. MP28-09 HIGH SERUM DEHYDROEPIANDROSTERONE EXAMINED BY ULTRASENSITIVE LIQUID-CHROMATOGRAPHY TANDEM MASS SPECTROMETRY AS A PREDICTOR OF BENIGN PROSTATE OR GLEASON SCORE ≤7 CANCER IN MEN WITH PROSTATE-SPECIFIC ANTIGEN LEVELS BELOW 10 NG/ML

30. A case of ductal carcinoma of the prostate after transurethral resection of prostate

32. 前立腺癌のLH-RHアゴニストによる治療における, ホスフェストロール及びクロルマジノンによるフレアー現象の抑制効果について

33. Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naïve prostate cancer

34. Prognostic significance of clinical stage including extent of disease (EOD) in prostate cancer

35. Comparative histological analysis of needle biopsy specimens, prostatectomized specimens and metastatic lymph nodes in prostatic adenocarcinoma--on the basis of the WHO histological classification

37. Combination therapy with estrogen and UFT in newly diagnosed prostatic cancer (poorly differentiated, stage D2)

38. Prostatic carcinoma presenting as an abdominal mass: a case report

39. High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients

40. Clinical and pathological study of 152 cases of prostatic cancer

41. Clinical studies on endocrine therapy for prostatic carcinoma (5): Analyses of relapse from endocrine therapy

42. Clinical studies on endocrine therapy for prostatic carcinoma (4): Initial response to endocrine therapy and prognosis

43. Clinical studies on endocrine therapy of prostatic carcinoma (3): Histopathological features of prostatic carcinoma and its prognosis

44. Clinical studies on endocrine therapy of prostatic carcinoma (2): Prognosis of patients with prostatic carcinoma given endocrine therapy, and analyses of causes of death and side effects of endocrine therapy

45. Clinical studies on endocrine therapy of prostatic carcinoma (1): Multivariate analyses of prognostic factors in patients with prostatic carcinoma given endocrine therapy

46. High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients

48. Phase I/II clinical trials of carbon ion therapy for prostate cancer

Catalog

Books, media, physical & digital resources